Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response

Yung Li Hung, Shih Hua Fang, Shu Chi Wang, Wei Chung Cheng, Po Len Liu, Chia Cheng Su, Chi Shuo Chen, Ming Yii Huang, Kuo Feng Hua, Kun Hung Shen, Yu Ting Wang, Katsuhiko Suzuki, Chia Yang Li

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Corylin is a main compound isolated from Psoralea corylifolia L. (Fabaceae). A variety of pharmacological effects such as antioxidant, anti-proliferation, and anti-inflammatory properties of corylin have been reported. Nevertheless, the effect of corylin in microbial infection and sepsis remains unclear. In the present study, we investigated the anti-inflammatory effects of corylin. Our experimental results demonstrated that corylin inhibited the production of TNF-α, IL-6 and NO by both LPS-Activated RAW 264.7 cells and LPS-Activated murine peritoneal macrophages. Moreover, corylin suppressed the expression levels of iNOS and COX-2, reduced the production of PGE 2 and HMGB1, blocked the translocation of HMGB1 from the nucleus to cytosol, and decreased the phosphorylation of MAPKs in LPS-Activated RAW 264.7 cells as well as suppressed the activity of NF-kappa; B in LPS-Activated J-Blue cells. In addition, the administration of corylin reduced the production of NO and TNF-α, decreased LPS-induced liver damage markers (AST and ALT) and kidney damage markers (BUN and CRE), attenuated infiltration of inflammatory cells and tissue damage of lung, liver and kidney, and enhanced the survival rate of LPS-challenged mice. Taken together, these results show the anti-inflammatory properties of corylin on LPS-induced inflammation and sepsis. Corylin could potentially be a novel anti-inflammatory and immunosuppressive drug candidate in the treatment of sepsis and septic shock.

Original languageEnglish
Article number46299
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 2017 Apr 11
Externally publishedYes

Fingerprint

Sepsis
Anti-Inflammatory Agents
HMGB1 Protein
Psoralea
Kidney
corylin
Liver
Blood Urea Nitrogen
Peritoneal Macrophages
Immunosuppressive Agents
Septic Shock
Prostaglandins E
Fabaceae
Cytosol
Interleukin-6
Antioxidants
Phosphorylation
Pharmacology
Inflammation
Lung

ASJC Scopus subject areas

  • General

Cite this

Hung, Y. L., Fang, S. H., Wang, S. C., Cheng, W. C., Liu, P. L., Su, C. C., ... Li, C. Y. (2017). Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response. Scientific Reports, 7, [46299]. https://doi.org/10.1038/srep46299

Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response. / Hung, Yung Li; Fang, Shih Hua; Wang, Shu Chi; Cheng, Wei Chung; Liu, Po Len; Su, Chia Cheng; Chen, Chi Shuo; Huang, Ming Yii; Hua, Kuo Feng; Shen, Kun Hung; Wang, Yu Ting; Suzuki, Katsuhiko; Li, Chia Yang.

In: Scientific Reports, Vol. 7, 46299, 11.04.2017.

Research output: Contribution to journalArticle

Hung, YL, Fang, SH, Wang, SC, Cheng, WC, Liu, PL, Su, CC, Chen, CS, Huang, MY, Hua, KF, Shen, KH, Wang, YT, Suzuki, K & Li, CY 2017, 'Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response', Scientific Reports, vol. 7, 46299. https://doi.org/10.1038/srep46299
Hung, Yung Li ; Fang, Shih Hua ; Wang, Shu Chi ; Cheng, Wei Chung ; Liu, Po Len ; Su, Chia Cheng ; Chen, Chi Shuo ; Huang, Ming Yii ; Hua, Kuo Feng ; Shen, Kun Hung ; Wang, Yu Ting ; Suzuki, Katsuhiko ; Li, Chia Yang. / Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response. In: Scientific Reports. 2017 ; Vol. 7.
@article{c525511f75ca440a99878da841a6edfa,
title = "Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response",
abstract = "Corylin is a main compound isolated from Psoralea corylifolia L. (Fabaceae). A variety of pharmacological effects such as antioxidant, anti-proliferation, and anti-inflammatory properties of corylin have been reported. Nevertheless, the effect of corylin in microbial infection and sepsis remains unclear. In the present study, we investigated the anti-inflammatory effects of corylin. Our experimental results demonstrated that corylin inhibited the production of TNF-α, IL-6 and NO by both LPS-Activated RAW 264.7 cells and LPS-Activated murine peritoneal macrophages. Moreover, corylin suppressed the expression levels of iNOS and COX-2, reduced the production of PGE 2 and HMGB1, blocked the translocation of HMGB1 from the nucleus to cytosol, and decreased the phosphorylation of MAPKs in LPS-Activated RAW 264.7 cells as well as suppressed the activity of NF-kappa; B in LPS-Activated J-Blue cells. In addition, the administration of corylin reduced the production of NO and TNF-α, decreased LPS-induced liver damage markers (AST and ALT) and kidney damage markers (BUN and CRE), attenuated infiltration of inflammatory cells and tissue damage of lung, liver and kidney, and enhanced the survival rate of LPS-challenged mice. Taken together, these results show the anti-inflammatory properties of corylin on LPS-induced inflammation and sepsis. Corylin could potentially be a novel anti-inflammatory and immunosuppressive drug candidate in the treatment of sepsis and septic shock.",
author = "Hung, {Yung Li} and Fang, {Shih Hua} and Wang, {Shu Chi} and Cheng, {Wei Chung} and Liu, {Po Len} and Su, {Chia Cheng} and Chen, {Chi Shuo} and Huang, {Ming Yii} and Hua, {Kuo Feng} and Shen, {Kun Hung} and Wang, {Yu Ting} and Katsuhiko Suzuki and Li, {Chia Yang}",
year = "2017",
month = "4",
day = "11",
doi = "10.1038/srep46299",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response

AU - Hung, Yung Li

AU - Fang, Shih Hua

AU - Wang, Shu Chi

AU - Cheng, Wei Chung

AU - Liu, Po Len

AU - Su, Chia Cheng

AU - Chen, Chi Shuo

AU - Huang, Ming Yii

AU - Hua, Kuo Feng

AU - Shen, Kun Hung

AU - Wang, Yu Ting

AU - Suzuki, Katsuhiko

AU - Li, Chia Yang

PY - 2017/4/11

Y1 - 2017/4/11

N2 - Corylin is a main compound isolated from Psoralea corylifolia L. (Fabaceae). A variety of pharmacological effects such as antioxidant, anti-proliferation, and anti-inflammatory properties of corylin have been reported. Nevertheless, the effect of corylin in microbial infection and sepsis remains unclear. In the present study, we investigated the anti-inflammatory effects of corylin. Our experimental results demonstrated that corylin inhibited the production of TNF-α, IL-6 and NO by both LPS-Activated RAW 264.7 cells and LPS-Activated murine peritoneal macrophages. Moreover, corylin suppressed the expression levels of iNOS and COX-2, reduced the production of PGE 2 and HMGB1, blocked the translocation of HMGB1 from the nucleus to cytosol, and decreased the phosphorylation of MAPKs in LPS-Activated RAW 264.7 cells as well as suppressed the activity of NF-kappa; B in LPS-Activated J-Blue cells. In addition, the administration of corylin reduced the production of NO and TNF-α, decreased LPS-induced liver damage markers (AST and ALT) and kidney damage markers (BUN and CRE), attenuated infiltration of inflammatory cells and tissue damage of lung, liver and kidney, and enhanced the survival rate of LPS-challenged mice. Taken together, these results show the anti-inflammatory properties of corylin on LPS-induced inflammation and sepsis. Corylin could potentially be a novel anti-inflammatory and immunosuppressive drug candidate in the treatment of sepsis and septic shock.

AB - Corylin is a main compound isolated from Psoralea corylifolia L. (Fabaceae). A variety of pharmacological effects such as antioxidant, anti-proliferation, and anti-inflammatory properties of corylin have been reported. Nevertheless, the effect of corylin in microbial infection and sepsis remains unclear. In the present study, we investigated the anti-inflammatory effects of corylin. Our experimental results demonstrated that corylin inhibited the production of TNF-α, IL-6 and NO by both LPS-Activated RAW 264.7 cells and LPS-Activated murine peritoneal macrophages. Moreover, corylin suppressed the expression levels of iNOS and COX-2, reduced the production of PGE 2 and HMGB1, blocked the translocation of HMGB1 from the nucleus to cytosol, and decreased the phosphorylation of MAPKs in LPS-Activated RAW 264.7 cells as well as suppressed the activity of NF-kappa; B in LPS-Activated J-Blue cells. In addition, the administration of corylin reduced the production of NO and TNF-α, decreased LPS-induced liver damage markers (AST and ALT) and kidney damage markers (BUN and CRE), attenuated infiltration of inflammatory cells and tissue damage of lung, liver and kidney, and enhanced the survival rate of LPS-challenged mice. Taken together, these results show the anti-inflammatory properties of corylin on LPS-induced inflammation and sepsis. Corylin could potentially be a novel anti-inflammatory and immunosuppressive drug candidate in the treatment of sepsis and septic shock.

UR - http://www.scopus.com/inward/record.url?scp=85017358847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017358847&partnerID=8YFLogxK

U2 - 10.1038/srep46299

DO - 10.1038/srep46299

M3 - Article

C2 - 28397806

AN - SCOPUS:85017358847

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 46299

ER -